Search

Your search keyword '"Laezza, C."' showing total 288 results

Search Constraints

Start Over You searched for: Author "Laezza, C." Remove constraint Author: "Laezza, C."
288 results on '"Laezza, C."'

Search Results

151. Impacts of Environmental Pollution on Brain Tumorigenesis.

152. Cannabinoids in the Modulation of Oxidative Signaling.

153. N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells.

154. Fungal Contamination in Microalgal Cultivation: Biological and Biotechnological Aspects of Fungi-Microalgae Interaction.

155. Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases.

156. N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells.

157. Cannabinoids: Therapeutic Use in Clinical Practice.

158. Sulfur Starvation in Extremophilic Microalga Galdieria sulphuraria : Can Glutathione Contribute to Stress Tolerance?

159. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.

160. Association of Alpha B-Crystallin Expression with Tumor Differentiation Grade in Colorectal Cancer Patients.

161. Molecular Mechanism of Cannabinoids in Cancer Progression.

162. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.

163. PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress.

164. Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer.

166. The Endocannabinoid System: A Target for Cancer Treatment.

167. N 6 -Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression.

168. N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor.

169. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.

170. Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.

171. Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.

172. Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa.

173. Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.

174. Cannabidiol: State of the art and new challenges for therapeutic applications.

175. The isoprenoid derivative N 6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.

176. PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells.

177. Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

178. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.

179. Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response.

180. Endocannabinoid System in Neurological Disorders.

181. Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

182. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

183. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.

184. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.

185. Statins in neurological disorders: an overview and update.

186. 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.

187. Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.

188. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.

189. N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.

190. Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives.

191. PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines.

192. Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis.

193. Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells.

194. Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

195. Cannabinoid type 1 receptor gene polymorphism and macronutrient intake.

196. Pharmacological actions of statins: a critical appraisal in the management of cancer.

197. Update on the endocannabinoid system as an anticancer target.

198. Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice.

199. Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.

200. Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.

Catalog

Books, media, physical & digital resources